Warnex Medical Laboratories

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Warnex announced that it has sold its medical laboratories division to Gamma-Dynacare Medical Laboratories for C$7.5 million (US$7.3 million).

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Warnex today said that it has signed an agreement to serve as exclusive distributor of 10 of DeCode Genetics' tests in Canada.

New Releases

Premium

Septin9 Colorectal Cancer Test

The company's Medical Laboratories testing and services division has received a renewal of its COLA accreditation.

So far this year, Rosetta has found commercialization partners for the diagnostics in the Middle East, Canada, the US, and India.

Warnex will market the tests and send tissue samples from its customers to Rosetta's Philadelphia-based lab for analysis.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.